Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

The Effect of Topical Rebamipide 2% in Managing Dry Eye Following Cataract Surgery: Ji Hyung Suh, Sung Kun Chung; J Korean Ophthalmol Soc. 2024;65(9):589-595. Published online September 13, 2024; DOI: https://doi.org/10.3341/jkos.2024.65.9.589
Web of Science 2 Crossref 4; Full text PubReader ePub PDF

Inflammatory Factors Predicting Dry Eye Syndrome in a Model Using Osmotic Pressure: Keon Woo Park, Jae Woong Koh; J Korean Ophthalmol Soc. 2023;64(12):1191-1197. Published online December 15, 2023; DOI: https://doi.org/10.3341/jkos.2023.64.12.1191; Full text PubReader ePub PDF

The Efficacies and Safeties of a 0.05% Cyclosporine Nanoemulsion and a 0.1% Cyclosporine Cationic Emulsion: Man Ji, Chul Young Choi, Seong-Jae Kim, Jinho Jeong; J Korean Ophthalmol Soc. 2022;63(10):834-840. Published online October 14, 2022; DOI: https://doi.org/10.3341/jkos.2022.63.10.834
Web of Science 1 Crossref 1; Full text PubReader ePub PDF

Effects of Platelet-rich Plasma on Ocular Surface in Patients with Dry Eye Syndrome: Clinico-experimental Analysis.: Jae Uk Jung, Sang Hee Lee, Hong Kyun Kim; J Korean Ophthalmol Soc. 2019;60(12):1169-1175. Published online December 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.12.1169
Web of Science 2 Crossref 5; PDF

Clinical Symptoms and Signs of Dry Eye Disease after Allogeneic Hematopoietic Stem Cell Transplantation.: Jin Uk Beak, Min Ji Ha, Rowoon Yi, Young Sik Yoo, Hyun Seung Kim, Kyung Sun Na; J Korean Ophthalmol Soc. 2019;60(12):1148-1154. Published online December 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.12.1148; PDF

Comparison of Efficacy and Sensation of Instillation between 0.05% Cyclosporine Nanoemulsion and Microemulsion Type.: Eun Hae Shin, Dong Hui Lim, Chan Min Yang, Tae Young Chung; J Korean Ophthalmol Soc. 2019;60(3):239-245. Published online March 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.3.239
Web of Science 4 Crossref 3; PDF

Comparisons for Evaluation of Efficacy and Safety of Cyclosporin A 0.05% Ophthalmic Emulsion Treatment Groups.: Soonwon Yang, Yong Soo Byun, Chang Rae Rho et al.; J Korean Ophthalmol Soc. 2016;57(12):1849-1856. Published online December 15, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.12.1849
Crossref 7; PDF

Volume 67, No. 5

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

6,505	Self-assessment of Visual Acuity Using a Smartphone Application
4,602	Accuracy of Intraocular Lens Power Prediction Using 9 Formula
3,075	Central Anticholinergic Syndrome Induced by Atropine Eye Drops: A Case Report
1,768	Efficacy of 1% Ivermectin Ointment for Demodex Blepharitis
3,253	Short-term Outcomes of Ranibizumab Biosimilar CKD-701 Treatment in Macular Edema Secondary to Retinal Vein Occlusion

Cited By 4	The Effect of Topical Rebamipide 2% in Managing Dry Eye Following Cataract Surgery
Cited By 3	A Case of Retinal Vasculitis, Uveitis in Myelin Oligodendrocyte Glycoprotein Antibody Associated Optic Neuritis
Cited By 2	What Laboratory Examinations for Open-angle Glaucoma Risk Stratification
Cited By 2	Comparison of Clinical Outcomes Among Sutured, Sutureless Scleral Fixation, and Retropupillary Fixation of Intraocular Lens
Cited By 2	Short-term Outcomes of Ranibizumab Biosimilar CKD-701 Treatment in Macular Edema Secondary to Retinal Vein Occlusion

Editorial Office: #1001, Jeokseon Hyundai BD
130, Sajik-ro, Jongno-gu, Seoul 03170, Korea
Tel: +82-2-2271-6603 Fax: +82-2-2277-5194 E-mail: kos@ijpnc.com

Copyright © 2026 by Korean Ophthalmological Society.

prev

next